WuXi AppTec

History

YearDetail
2000 The company was established.
2001 The company launched synthetic chemistry services.
2003 The company started manufacturing process development services.
2004 The company initiated manufacturing services for research and development.
2005 The company started bio-analytical services.
2007 The company was listed on the New York Stock Exchange.
2008 The company acquired AppTec Laboratory Services and was renamed as WuXi AppTec.
2011 The company acquired Medkey to expand clinical development and registration services.
2014 The company acquired XenoBiotic Laboratories to accelerate its research capabilities.
2015 The company was delisted from the New York Stock Exchange.
2017 The company acquired HD Biosciences to strengthen its biology R&D capacity and capabilities.
2018 The company was listed on the on Shanghai Exchange and Hong Kong Exchange.
2019 The company acquired Pharmapace to enhance biometrics services for clinical development.
2021 The company acquired OXGENE to strengthen further cell and gene therapy service offerings for global customers.